arrow
L

Laura Edwards

Clalit Health Services
H指数:16
被引数:2,111

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improved Immune Response Against Influenza A Viruses With Receipt of a Recombinant Influenza Vaccine in Healthcare Personnel With Prior Low Antibody Response to Egg-Based Influenza Vaccines, Israel, 2019-2020

在以色列2019-2020年,对先前对蛋基流感疫苗低抗体反应的医疗保健人员,通过接种重组流感疫苗来改善对甲型流感病毒的免疫应答。

2025-12-010
PRE
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections

固有免疫原性是SARS-CoV-2感染中类型特异性反应的主要决定因素。

2025-05-270
PRE
Association of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination and Reductions in Post COVID Conditions Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a US Prospective Cohort of Essential Workers

信使RNA冠状病毒疾病2019 (新型冠状病毒肺炎) 疫苗接种与新型冠状病毒冠状病毒2感染后COVID后病情减少的关联

2024-11-130
OA
Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022-2023: A Prospective Cohort Study
2024-10-240
OA
Hybrid Immunity and Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort Study
2024-03-111
PRE
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines
2024-01-047
OAAI
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020
2023-04-218
OAAI
Test-to-Stay After SARS-CoV-2 Exposure: A Mitigation Strategy for Optionally Masked K-12 Schools
2022-10-216
OA
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial

重复接种疫苗对18-64岁医护人员四价细胞培养和重组流感疫苗免疫原性的影响: 一项随机、开放标签试验

2022-08-299
OAAI
School Masking Policies and Secondary SARS-CoV-2 Transmission
2022-05-2032
OA
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
2022-05-1229
OAAI
Test-to-Stay After Exposure to SARS-CoV-2 in K-12 Schools
2022-04-1913
OA
Masking Adherence in K-12 Schools and SARS-CoV-2 Secondary Transmission
2022-02-0110
OA
Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021
2022-01-135
OAAI
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection

mRNA-1273和BNT162b2冠状病毒病2019 (新型冠状病毒肺炎) 疫苗对假型新型冠状病毒 (SARS-CoV-2) 的中和抗体反应因SARS-CoV-2感染史而不同

2021-12-2010
OA
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
2021-07-22356
OAAI
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial
2021-07-1027
OA